ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Risk factors"

  • 2016 American Transplant Congress

    Evaluating Associations Between Clinical and Psychosocial Risk Factors and Adverse Post-Transplant Events in High Risk Renal Transplant Recipients.

    C. Yellman, D. Destiche, A. DeMers, I. Feurer, M. Via, C. Gamble, H. Schaefer.

    Kidney/Pancreas Transplant, Vanderbilt University Medical Center, Nashville, TN.

    Kidney transplant recipients (KTRs) require a complex medical regimen in the post-transplant period that can be difficult to navigate and if not followed, significant complications…
  • 2016 American Transplant Congress

    Muscle Density Is Associated with Mortality Among Kidney Waitlist Candidates.

    R. Reed,1 S. Nair,2 G. Smith,1 C. Lewis,1 J. Terry,2 J. Carr,2 J. Locke.1

    1School of Medicine, University of Alabama at Birmingham, Birmingham, AL; 2School of Medicine, Vanderbilt University, Nashville, TN.

    Background: Morphometric assessments, such as muscle density and body fat distribution, have emerged as strong predictors of cardiovascular risk and post-operative morbidity and mortality. To…
  • 2016 American Transplant Congress

    Risk Factors for the Development of CMV Viremia in a Cohort of Morbidly Obese Kidney Transplant Recipients Under Low Dose Valganciclovir Prophylaxis.

    J. Thielke,1 N. Jasiak,1 N. Hilal,1 S. Salah,1 E. Benedetti,2 P. West-Thielke.2

    1Pharmacy Practice, Univ of IL-Chicago Medical Center, Chicago, IL; 2Dept of Surgery, Univ of IL-Chicago Medical Center, Chicago, IL.

    Background: The rate of Cytomegalovirus infections in kidney transplant recipients drastically diminished with the advent of oral ganciclovir and subsequently valganciclovir. However it continues to…
  • 2016 American Transplant Congress

    The Association of Life Expectancy by Resident Zip Code and Kidney Transplant Outcomes – What Is True Baseline Risk?

    L. Buccini, D. Goldfarb, E. Poggio, S. Flechner, J. Schold.

    Cleveland Clinic, Cleveland, OH.

    Many factors beyond traditional clinical risk factors and demographics are associated with outcomes in the general population. These include behavioral, economic, genetic and environmental risks…
  • 2015 American Transplant Congress

    Patient and Process-Level Factors Associated With Kidney Transplant Readmissions

    K. Covert, J. Fleming, C. Staino, J. Casale, K. Boyle, N. Pilch, H. Meadows, C. Mardis, J. McGillicuddy, C. Bratton, T. Srinivas, K. Chavin, P. Baliga, D. Taber.

    MUSC, Charleston, SC.

    Readmissions following kidney transplantation (KTX) are common, with complex etiologies. There is a lack of research exploring the potential of optimizing post-transplant processes to reduce…
  • 2015 American Transplant Congress

    Diabetes Mellitus and Prediabetes On Kidney Transplant Waiting List – Prevalence, Metabolic Phenotyping and Risk Stratification Approach

    M. Guthoff,1 D. Vosseler,1 J. Langanke,1 S. Nadalin,2 A. Königsrainer,2 H.-U. Häring,1 A. Fritsche,1 N. Heyne.1

    1Dept. of Endocrinology and Diabetology, Angiology, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany; 2Dept. of General, Visceral and Transplant Surgery, University of Tübingen, Tübingen, Germany.

    Purpose: Diabetes mellitus (DM), the most common cause of ESRD, limits access to transplantation and impairs patient and allograft outcome. Prediabetes is an independent risk…
  • 2015 American Transplant Congress

    Obesity: A Major Risk Factor for Wound and Parietal Complications in Renal Transplantation

    H. Andrade, W. Nahas, R. Kato, K. Yamaçake, H. Kanashiro, I. Antonopoulos, A. Bull, R. Falci, A. Piovesan.

    Division of Urology, Renal Transplantation Unit, University of Sao Paulo, Sao Paulo, Brazil.

    Purpose: The increase of obesity among patients with end-stage renal disease poses a major challenge for urologists and nephrologists. Many centers set an upper limit…
  • 2015 American Transplant Congress

    Early Hospital Readmission After Simultaneous Pancreas-Kidney Transplantation

    E. King,1 L. Kucirka,1 M. McAdams-DeMarco,1,2 A. Massie,1,2 D. Segev.1,2

    1Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD; 2Epidemiology, Johns Hopkins University, School of Public Health, Baltimore, MD.

    Background: Early hospital readmission (EHR) is associated with increased morbidity and mortality after kidney transplantation. However, following simultaneous pancreas-kidney transplantation (SPK), EHR rates are unknown,…
  • 2015 American Transplant Congress

    Pre-Transplant Cardiac Troponin T (cTT) Is a Strong Predictor of Post Kidney Transplant Hospitalizations

    H. Amer, P. Geerdes, T. Fettes, R. Walker, E. Lorenz, F. Cosio.

    The William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN.

    Identifying patients at risk of re-hospitalization will permit improved monitoring and may decrease morbidity.We examined nine objective variables at the time of transplant and their…
  • 2015 American Transplant Congress

    Everolimus-Based Immunosuppression Is Associated With a Reduced Risk of New-Onset Malignancies After Liver Transplantation

    P. De Simone,1 P. Carrai,1 L. Coletti,1 D. Ghinolfi,1 D. Campani,2 F. Filipponi.1

    1Hepatobiliary Surgery and Liver Transplantation, University of Pisa Medical School Hospital, Pisa, Italy; 2Pathology, University of Pisa Medical School Hospital, Pisa, Italy.

    Background and aim: The inhibitor of the mammalian target of rapamycin (mTOR) everolimus (EVR) has shown anti-proliferative effects in experimental and clinical models. We investigated…
  • « Previous Page
  • 1
  • …
  • 46
  • 47
  • 48
  • 49
  • 50
  • …
  • 55
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences